Table 2 Summary (mean ± SE) of cardiac pulse wave, tissue Doppler and M-mode imaging parameters measured before (pre) and after treatment (post) with the SGLT-2 inhibitor

665 ± 28

641 ± 40

696 ± 50

632 ± 25

680 ± 29

647 ± 57

455 ± 34

508 ± 19

463 ± 34

417 ± 24

510 ± 31

470 ± 45

1.52 ± 0.12

1.26 ± 0.05

1.53 ± 0.12

1.5 ± 0.08

1.35 ± 0.09

1.39 ± 0.06

29.4 ± 3.0

32.7 ± 3.9

27.8 ± 1.8

24.9 ± 1.8

31.1 ± 3.3

26.3 ± 1.8

27.0 ± 1.8

14.0 ± 1.6*

15.9 ± 2.2

26.9 ± 1.4

15.5 ± 1.7*

20.4 ± 1.2

21.5 ± 2.5

16.6 ± 0.8

18.0 ± 4.1

19.0 ± 1.7

18.3 ± 2.7

11.9 ± 0.9^§

1.31 ± 0.09

0.84 ± 0.08*

0.93 ± 0.07^§

1.47 ± 0.11

0.89 ± 0.08*^,†

1.76 ± 0.17

25.3 ± 1.7

48 ± 5.6*

47 ± 2.5^§

24 ± 1.6

46 ± 4.4*^,†

29 ± 1.8

8.7 ± 0.4

13.4 ± 1.8

12.4 ± 0.6

7.8 ± 0.5

12.3 ± 1.3*^,†

7.8 ± 0.9

20.9 ± 1.8

19.9 ± 0.8

18.0 ± 1.0

19.0 ± 2.3

16.0 ± 0.4

15.8 ± 0.4

1.55 ± 0.10

2.35 ± 0.13*

2.25 ± 0.10^§

1.40 ± 0.06

1.97 ± 0.03*

2.04 ± 0.1^§

1.21 ± 0.06

1.37 ± 0.02

1.42 ± 0.05

1.26 ± 0.06

1.29 ± 0.02

1.27 ± 0.05

1.29 ± 0.07

1.72 ± 0.09*

1.60 ± 0.11^a

1.14 ± 0.08

1.54 ± 0.11*

1.61 ± 0.1^§

72 ± 6

76 ± 1

71 ± 2

74 ± 2

74 ± 3

76 ± 2

42 ± 5

44 ± 1

39 ± 2

42 ± 2

43 ± 3

45 ± 2

21 ± 2

41 ± 5*

41 ± 4^§

29 ± 3

49 ± 5*

39 ± 5

56 ± 4

101 ± 11*

95 ± 5^§

63 ± 7

108 ± 9*

87 ± 10

0.70 ± 0.07

0.91 ± 0.05*

0.85 ± 0.04

0.81 ± 0.05

0.82 ± 0.11

0.84 ± 0.05

3.40 ± 0.14

3.52 ± 0.11

3.68 ± 0.14

3.50 ± 0.05

3.79 ± 0.17

3.86 ± 0.19

0.69 ± 0.04

0.83 ± 0.04*

0.78 ± 0.04

0.75 ± 0.02

0.92 ± 0.09

0.83 ± 0.05

2.00 ± 0.24

1.96 ± 0.08

2.23 ± 0.13

2.13 ± 0.12

2.28 ± 0.17

2.27 ± 0.11

0.41 ± 0.03

0.49 ± 0.03

0.45 ± 0.03

0.45 ± 0.02

0.48 ± 0.08

0.43 ± 0.03

59 ± 3

86 ± 4*

81 ± 3^§

76 ± 3

97 ± 7

98 ± 9

4.30 ± 0.17

5.56 ± 0.36

5.71 ± 0.52